ArticleCancer research2020

Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.

Elavarasan Subramani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.